Azitra is developing ATR04-484 for the treatment of EGFR inhibitor-associated rash with plans to dose first patient in Phase 1/2 trial in the first half of 2025 "We look forward to presenting an ...
The MarketWatch News Department was not involved in the creation of this content. ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis ...
This localized campaign demonstrates ATR’s commitment to making secure, sustainable, and cost-effective IT asset management more accessible to new clients in the region. The new program enables ...
Advanced Technology Recycling (ATR), a Florida-based recycling center specializing in information technology asset disposition (ITAD) and R2v3/RIOS certified electronics recycling, has launched a ...
Azitra (AZTR) is developing ATR04-484 for the treatment of EGFR inhibitor-associated rash with plans to dose first patient in Phase 1/2 trial in the first half of 2025 BRANFORD, Conn., April 25, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results